Paraquat under U.S. scrutiny over potential Parkinson’s link

David Jilbert, a 65-year-old Ohio vineyard owner and Parkinson’s patient, used to spray paraquat, a controversial herbicide, on his crops. Years later, afflicted with Parkinson’s disease, he believes his condition is linked to his past herbicide use. Jilbert’s concerns were echoed at a recent U.S. Congressional hearing, attended by individuals advocating for stricter regulations on paraquat. Despite being banned in over 70 countries, including its manufacturing base in Britain and China, paraquat is still approved for use in the United States under stringent guidelines upheld by the Environmental Protection Agency (EPA).

The EPA is poised to release a final report on paraquat by January 17, after reviewing 90 new scientific studies, an initiative spearheaded by the Michael J. Fox Foundation. However, Syngenta, the company owning the paraquat brand, denies any causal connection between the herbicide and Parkinson’s disease, asserting that the product is safe when used as directed. This stance is contested by numerous studies indicating a heightened Parkinson’s risk among those exposed to paraquat.

Dr. David Blacker, an Australia-based neurologist, criticized the chemical industry’s reliance on the difficulty of proving direct causation, advocating for the precautionary principle when public health risks are suspected. Meanwhile, Parkinson’s survivors like Jilbert and Charlene Tenbrink, who also links her condition to paraquat use, have initiated lawsuits against Syngenta, reminiscent of past legal battles against Big Tobacco.

As the legal and regulatory scrutiny intensifies, Jilbert reflects on his decision to become a farmer and the dire consequences of trusting regulated chemicals. The ongoing litigation and EPA’s forthcoming decision could mark significant milestones in the continuing debate over paraquat’s safety and its impact on public health.